Regulatory announcements, news and linked financial reports. Source type, retrieved content and timestamp conflicts stay visible.
12 documents returned
News
Photocure to webcast Q2 2026 results presentation
Alliance News·Published 11 Sept 2026· EN
Excerpt from the provider feedDates conflict
(AWP Alliance News) - Photocure set its second-quarter 2026 results for release on July 29, 2026 at 08:00 CEST. A live webcast presentation is scheduled for July 29, 2026 at 14:00 CEST. The quarterly report and presentation will be posted at https://www.photocure.com. The webcast will stream at https://qcnl.tv/p/FjEYoKWacAN-FYhADjmt6A. https://www.publicnow.com/view/896A3EFCD8410B7C68D90E1E033B121BAED1F841/117424 Disclaimer: This news brief was created using generative artifi…
Sandbox date 11 Sept 2026; original document date 22 Jul 2026. Chronology is not verified.
Regulatory announcement
Photocure ASA: Invitation to presentation of second quarter 2026 financial results
Oslo Børs NewsPoint·Published 11 Sept 2026· EN
Excerpt from the provider feedDates conflict
Oslo, Norway, 22 July 2026: Photocure ASA (Photocure, PHO: OSE) will announcethe second quarter 2026 financial results on Wednesday 29 July 2026 at 08:00CEST and will present a live webcast at 14:00 CEST the same day.The quarterly report and presentation will be published at 08:00 CEST and willbe publicly available at www.photocure.com.The investor presentation will be streamed live and hosted by Dan Schneider,CEO, Priyam Shah, VP of Investor Relations and Dick Peters, VP Fin…
Sandbox date 11 Sept 2026; original document date 22 Jul 2026. Chronology is not verified.
News
Photocure ASA: Invitation to presentation of second quarter 2026 financial results
Cision·Published 11 Sept 2026· EN
No link or excerptDates conflict
Sandbox date 11 Sept 2026; original document date 22 Jul 2026. Chronology is not verified.
News
Photocure Study Finds Office-Based Laser Coagulation Non-Inferior to TUR-BT for Bladder Tumor Recurrence
Alliance News·Published 9 Sept 2026· EN
Excerpt from the provider feedDates conflict
(AWP Alliance News) - Photocure ASA has announced the publication of a clinical study titled "In-office laser coagulation of Ta bladder tumor compared to TUR-BT: 12 months follow-up randomized clinical trial" in the Journal of Urology. The study, supported by Photocure since 2016 and previously presented in abstract form at the European Association of Urology (EAU) 2024 congress, evaluated the 12-month recurrence-free survival (RFS) in patients with recurrent Ta low-grade bla…
Sandbox date 9 Sept 2026; original document date 8 Jan 2026. Chronology is not verified.
News
Photocure ASA publishes update to financial calendar
Alliance News·Published 30 Aug 2026· EN
Excerpt from the provider feedDates conflict
(AWP Alliance News) - Photocure ASA will publish its Q4 2025 quarterly report on 18 February 2026. The company's annual report for 2025 will be released on 13 April 2026. Photocure ASA will hold its annual general meeting for 2026 on 4 May 2026. The Q1 2026 quarterly report is scheduled for publication on 7 May 2026. The half-yearly report for 2026 will be released on 29 July 2026. Photocure ASA's Q3 2026 quarterly report is set for release on 28 October 2026. https://www.pub…
Sandbox date 30 Aug 2026; original document date 29 Dec 2025. Chronology is not verified.
Regulatory announcement
PHO: Financial calendar
Oslo Børs NewsPoint·Published 30 Aug 2026· EN
Excerpt from the provider feedDates conflict
Financial calendar for Photocure ASAFINANCIAL YEAR 202513.04.2026 - Annual Report18.02.2026 - Quarterly Report - Q4FINANCIAL YEAR 202629.07.2026 - Half-yearly Report04.05.2026 - Annual General Meeting07.05.2026 - Quarterly Report - Q128.10.2026 - Quarterly Report - Q3This information is published pursuant to the requirements set out in theContinuing obligations.
Sandbox date 30 Aug 2026; original document date 29 Dec 2025. Chronology is not verified.
Regulatory announcement
The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison
Oslo Børs NewsPoint·Published 9 Aug 2026· EN
Excerpt from the provider feedDates conflict
Press Release - Oslo, Norway, December 8th, 2025: Photocure ASA (OSE: PHO), theBladder Cancer Company, announces the presentation of a health economicsabstract from the BRAVO study at the Society of Urologic Oncology 2025 AnnualMeeting (SUO) December 2-5, 2025, in Phoenix, AZ. The abstract "COSTS OF CAREAND ONCOLOGIC OUTCOMES ASSOCIATED WITH BLUE LIGHT CYSTOSCOPY IN AN EQUAL ACCESSSETTING: RESULTS FROM THE BRAVO STUDY" compares costs in non-muscle-invasivebladder cancer (NMIB…
Sandbox date 9 Aug 2026; original document date 8 Dec 2025. Chronology is not verified.
News
Photocure: The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison
Cision·Published 9 Aug 2026· EN
No link or excerptDates conflict
Sandbox date 9 Aug 2026; original document date 8 Dec 2025. Chronology is not verified.
Financial report
Photocure · 2024 financial report
Photocure·Published 19 Feb 2025· EN
Link only · contents not retrievedChronology unverified
Financial report
Photocure · 2024-Q3 financial report
Photocure·Published 13 Nov 2024· EN
Link only · contents not retrievedChronology unverified
Financial report
Photocure · 2024-Q2 financial report
Photocure·Published 7 Aug 2024· EN
Link only · contents not retrievedChronology unverified
Financial report
Photocure · 2024-Q1 financial report
Photocure·Published 15 May 2024· EN
Link only · contents not retrievedChronology unverified
Sandbox source dates can reflect replayed data and conflict with modification or original document dates.
Documents are source candidates; no automatic evidence link to an insider or owner record is asserted.
The provider document contains no readable body.
A report or source link does not mean Finance has read the document. Only the provider-feed excerpts shown here were retrieved.
Millistream MWS sandbox · Retrieved 11 Sept, 20:21 UTC